Read More Pharma Industry News Wenda Pharma’s NHWD-870 breakthrough tag puts rare NUT carcinoma therapy in sharper focus A rare cancer has few targeted options. Wenda Pharma’s NHWD-870 now tests whether China can move faster in precision oncology. byVenkateshMay 9, 2026